myWAV vs. Avadel IH Study Utilizzo e statistiche
Download the myWAV app to help you get started and support your treatment. As the 24/7 online resource for adults who have been prescribed XYWAV® (calcium, magnesium, potassium, and sodium oxybates) oral solution, 0.5 g/mL total salts (equivalent to 0.413 g/mL of oxybate), this app puts information about XYWAV and answers to some of your questions right at your fingertips.
The myWAV app is your personalized tool to:
• HELP you get started and support your treatment
• ACCESS instructions for use, support programs, treatment tips and more
• RECEIVE treatment support tailored to your personal needs
• MEASURE your treatment progress
The myWAV app is intended for education, planning, and tracking purposes only, and is not a medical device. The myWAV app is not intended to offer or replace professional medical advice. It is intended for US audiences ages 18 and up only.
Please note that comments posted on the Apple App Store are not associated with or endorsed by Jazz Pharmaceuticals (Jazz). Jazz values your comments, questions, and concerns but will not respond to questions posted on iTunes. If you are experiencing a medical emergency, contact your healthcare professional immediately. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
To access the XYWAV full Prescribing Information, including BOXED Warning, and Medication Guide, visit https://pp.jazzpharma.com/pi/xywav.en.USPI.pdf and https://pp.jazzpharma.com/pi/xywav.en.MG.pdf
To access the Jazz Pharmaceuticals Privacy Policy visit https://www.jazzpharma.com/privacy-statement/
©2025 Jazz Pharmaceuticals plc or its subsidiaries US-XYW-2000257 Rev1025
- App Store di Apple
- Gratis
- Settore Medico
Classifica degli store
- -
This app is intended for use by participants in the Avadel IH study and requires an invitation and activation code from the study site to register. A Double-blind, Placebo-controlled, Randomized Withdrawal, Multicenter Study of the Efficacy and Safety of FT218 in the Treatment of Idiopathic Hypersomnia (IH) with an Open-Label Safety Extension. This study has been reviewed and approved by the appropriate regulatory body, e.g. Institutional Review Board (IRB) or Independent Ethics Committee (IEC).
Key App Features:
- Patient Onboarding – complete study app registration and education
- Activities – complete scheduled or on-demand study tasks and assessments
- Dashboard – review overall progress in the study and current activities
- Resources – view study information in the Learn section of the app
- Profile – manage account details and app settings
- Notifications – receive in-app reminders
About THREAD:
THREAD’s® purpose is to leverage its clinical research platform to enable studies for everyone, everywhere. The company’s uniquely combined clinical research technology and consulting services help life science organizations to design, operate, and scale next-generation research studies and electronic clinical outcome assessments (eCOA) programs for participants, sites, and study teams. Through its comprehensive platform and scientific expertise, THREAD empowers studies to be accessible, efficient, and centered on the patient.
- App Store di Apple
- Gratis
- Settore Medico
Classifica degli store
- -
myWAV VS. 
Avadel IH Studygennaio 20, 2026